Aziyo Biologics, Inc. (AZYO) Misses Q2 EPS by 36c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Aziyo Biologics Reports Second Quarter 2023 Financial Results - Transformation Continues to Drug-Eluting Biomatrix Company
August 14, 2023 4:05 PM EDTNegotiating multiple LOIs to divest Orthopedic business
CanGaroo® RM 510(k) resubmission to the FDA remains on track
SimpliDerm® quarterly net sales up 32% year-over-year
Successful transfer of Cardiovascular product distribution to LeMaitre Vascular
SILVER SPRING, Md., Aug. 14, 2023 (GLOBE NEWSWIRE) -- Aziyo Biologics, Inc. (Nasdaq: AZYO) (Aziyo), a company that develops and commercializes biologic products to improve compatibility between medical devices and the patients who need them, today provided a business update and reported... More
